top of page

Catalyzing deep tech startups to biologize the future

Convergente Lab is our biotech innovation hub in Distrito Tlalpan. We provide the strategic infrastructure, capacities, and capital necessary for deep tech startups to mitigate risk, validate their scientific developments, and confidently scale toward the global market from Mexico City.

The journey from a successful proof of concept in the laboratory to commercial validation is the most critical stretch for a science-based startup. In Latin America, biotech teams face a fragmented ecosystem characterized by a scarcity of equipped laboratories and a strong risk aversion from traditional capital.

Convergente Lab solves this market failure by transforming biological uncertainty into storable, computable, and investable scientific evidence. We operate in the execution phase of the technology cycle (Build-Test), functioning as the platform that eliminates material and financial entry barriers to consolidate high-survival companies.

Upcoming cohorts (2026)

Previous cohorts

Technical intelligence for policy action.

Anticipatory Governance

We train policymakers and regulators to design regulatory frameworks that foster technological innovation and secure national sovereignty.

Strategic Foresight

We instruct executive teams in designing future scenarios to guide long-term investments and mitigate systemic risks.

Ecosystem Articulation

We develop leaders capable of connecting scientific talent, venture capital, public policy, private investment and social impact.

Expanding portfolio

Our team continuously designs specialized training modules to address the emerging challenges of technological convergence.

Convergente - Isologo Blanco.png

Convergente es el espacio para el diseño y construcción de mejores futuros en la intersección entre biotecnología y tecnología.

Un joint venture de Allbiotech, Vexxel y Noxgen Biotech.

Donato Guerra 9, Tizapán San Ángel, Progreso Tizapán, Álvaro Obregón, 01090

Ciudad de México, CDMX

bottom of page